Actuate Therapeutics, Inc.
ACTU
$6.89
-$0.33-4.57%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 8.64M | 13.52M | 351.70K | 2.07M | 2.96M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 566.30K | 739.30K | 198.00K | 119.80K | 36.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 9.21M | 14.26M | 549.70K | 2.19M | 3.00M |
|
|
|||||
| Total Current Assets | 9.21M | 14.26M | 549.70K | 2.19M | 3.00M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 110.50K | -- | 1.18M | 510.50K | -- |
| Total Assets | 9.32M | 14.26M | 1.73M | 2.70M | 3.00M |
|
|
|||||
| Total Accounts Payable | 1.92M | 2.33M | 5.89M | 3.96M | 3.42M |
| Total Accrued Expenses | 6.88M | 6.17M | 6.34M | 5.78M | 3.50M |
| Short-term Debt | -- | -- | 6.90M | 5.00M | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | 936.70K | -- | -- |
| Total Other Current Liabilities | -- | -- | 936.70K | -- | -- |
| Total Current Liabilities | 8.80M | 8.50M | 20.07M | 14.73M | 6.92M |
|
|
|||||
| Total Current Liabilities | 8.80M | 8.50M | 20.07M | 14.73M | 6.92M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 6.90M | 5.00M | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 411.80K | 406.70K | 475.10K | 540.10K | 535.00K |
| Total Liabilities | 9.21M | 8.90M | 20.55M | 15.27M | 7.46M |
|
|
|||||
| Common Stock & APIC | 132.48M | 131.29M | 5.71M | 5.62M | 5.47M |
| Retained Earnings | -132.38M | -125.93M | -119.96M | -113.39M | -105.09M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 104.20K | 5.36M | -114.26M | -107.77M | -99.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | 94.18M | 94.18M | 94.18M |
| Preferred Stock, Others | -- | -- | 1.26M | 1.02M | 988.00K |
| Total Preferred Equity | -- | -- | 95.44M | 95.20M | 95.17M |
|
|
|||||
| Total Common Equity | 104.20K | 5.36M | -114.26M | -107.77M | -99.63M |
| Total Preferred Equity | -- | -- | 95.44M | 95.20M | 95.17M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 104.20K | 5.36M | -18.82M | -12.58M | -4.46M |
|
|
|||||
